Showing results (1-10 of 314) with videos related to

Sort By:
Pageof 32
Current Opinion in Rheumatology|November 1, 1994
Treatment of systemic sclerosisF H van den Hoogen, L B van de Putte
Clinical Rheumatology|September 1, 1990
Effects of immunomodulating therapy in systemic sclerosisF H van den Hoogen, A M Boerbooms, L B van de Putte
Annals of the Rheumatic Diseases|April 17, 2001
Isolated digital vasculitis in a patient with rheumatoid arthritis: good response to tumour necrosis factor alpha blocking treatmentA A den Broeder, F H van den Hoogen, L B van de Putte
The Journal of Rheumatology. Supplement|May 1, 1997
Hematopoietic stem cell transplants for autoimmune disease: role of EULAR. European League Against RheumatismL B van de Putte, A Tyndall, F H van den Hoogen, et al.
Annals of the Rheumatic Diseases|September 24, 1999
Superinduction of interleukin 8 mRNA in activated monocyte derived macrophages from rheumatoid arthritis patientsR J Rodenburg, F H van Den Hoogen, P Barrera, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 29, 1998
[High-dose chemotherapy followed by hematopoietic stem cell transplantation as therapy for systemic rheumatic autoimmune diseases]F H van den Hoogen, A V Schattenberg, F C Breedveld, et al.
The Journal of Clinical Investigation|February 14, 1998
Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodiesG A Schellekens, B A de Jong, F H van den Hoogen, et al.
Arthritis and Rheumatism|May 1, 1996
Aberrant expression pattern of the SS-B/La antigen in the labial salivary glands of patients with Sjögren's syndromeP C de Wilde, L Kater, C Bodeutsch, et al.
Annals of the Rheumatic Diseases|September 15, 2001
Prevention of symptomatic thrombosis with short term (low molecular weight) heparin in patients with rheumatoid arthritis after hip or knee replacementH A van Heereveld, R F Laan, F H van den Hoogen, et al.
Pageof 32